Letter to the Editor
Controversy regarding ACE inhibitors / ARBs in COVID-19Controversias sobre el tratamiento con IECA/ARA-II y COVID-19

https://doi.org/10.1016/j.rec.2020.04.004Get rights and content

Cited by (0)

View Abstract